Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glenmark Generics Ltd.

Division of Glenmark Pharmaceuticals Ltd.
www.glenmark-generics.com

Latest From ProStrakan Group PLC

AstraZeneca CEO Says Post-Crestor Future On Track As Pipeline Builds

AstraZeneca's first-half results presentation highlighted its growing early pipeline, notably in oncology, but also the increasing pain of generic erosion on its Crestor sales – underlining again the importance new drugs will play in the group's turnaround strategy.

United Kingdom Brexit

Biopharma Quarterly Dealmaking Statistics, Q1 2016

Q1 biopharma financing totaled $5.7 billion, a sharp drop from Q4, but this time early-stage venture rounds were the most popular fundraising vehicle;Q1 M&A also declined, totaling $12.3 billion, mostly from Mylan's $9.9 billion buy of Meda. The top alliance was again by Sanofi, in a five-year potential $2.26 billion collaboration with DiCE Molecules to develop oral small-molecule therapies against up to 12 targets.

BioPharmaceutical Deals

Deals Shaping the Medical Industry, April 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.

BioPharmaceutical Medical Device

Reihill and Stratford join Consilient Health board

Consilient Health, a UK-based generic and specialty pharmaceutical firm, has appointed Shane Reihill as non-executive chair and Harry Stratford as a non-executive director. Mr Reihill is the chair and founder of investment firm TVC Holdings while Mr Stratford founded Shire Pharmaceuticals and ProStrakan and is a former CEO of both companies.

See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Glenmark Pharmaceuticals Ltd.
  • Senior Management
  • Terrance J Coughlin, CEO
    Percy Birdy, VP, Fin.
  • Contact Info
  • Glenmark Generics Ltd.
    Phone: (91) 22 40 18 9999
    HDO-Corp. Bldg. Wing A
    Off W Express H
    Mumbai, 400099
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register